×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Thomas Desrosier

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
MCRBSeres Therapeutics, Inc.Thomas DesrosierSee RemarksAug 15, 2025Option/RSU Exercise-244-7,531Aug 19, 2025, 04:07 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierSee RemarksAug 18, 2025Sale$16.65761,2657,455Aug 19, 2025, 04:07 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPMay 15, 2025Option/RSU Exercise-244-7,366May 19, 2025, 04:05 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPMay 15, 2025Sale$7.28795757,287May 19, 2025, 04:05 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPFeb 15, 2025Option/RSU Exercise-11,564-146,756Feb 19, 2025, 08:07 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPFeb 18, 2025Sale$0.814,3003,485142,456Feb 19, 2025, 08:07 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPNov 15, 2024Option/RSU Exercise-2,656-136,070Nov 19, 2024, 04:21 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPNov 18, 2024Sale$0.54878475135,192Nov 19, 2024, 04:21 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPOct 27, 2024Option/RSU Exercise-13,500-137,673Oct 29, 2024, 06:26 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPOct 28, 2024Sale$0.694,2592,939133,414Oct 29, 2024, 06:26 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPAug 16, 2024Sale$0.84873733124,173Aug 19, 2024, 05:48 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPAug 15, 2024Option/RSU Exercise-2,656-125,046Aug 19, 2024, 05:48 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPMay 15, 2024Option/RSU Exercise-2,656-123,233May 17, 2024, 08:14 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPMay 15, 2024Sale$0.94843792122,390May 17, 2024, 08:14 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPFeb 15, 2024Option/RSU Exercise-10,625-124,516Feb 16, 2024, 09:48 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPFeb 16, 2024Sale$1.083,9394,254120,577Feb 16, 2024, 09:48 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPOct 27, 2023Option/RSU Exercise-13,501-118,047Oct 31, 2023, 09:39 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPOct 30, 2023Sale$1.354,1565,611113,891Oct 31, 2023, 09:39 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPJul 05, 2022Award/Grant$3.1563,492200,000104,546Jul 06, 2022, 07:29 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPJan 26, 2020Option/RSU Exercise-25,000-41,054Jan 28, 2020, 04:06 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPJan 26, 2019Option/RSU Exercise-15,000-21,525Jan 29, 2019, 06:55 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierChief Legal Officer and EVPJan 28, 2019Sale$5.755,47131,47816,054Jan 29, 2019, 06:55 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierSee RemarksJan 26, 2018Option/RSU Exercise-10,000-10,000Jan 30, 2018, 08:58 PM
MCRBSeres Therapeutics, Inc.Thomas DesrosierSee RemarksJan 26, 2018Sale$11.023,47538,2956,525Jan 30, 2018, 08:58 PM